Digital biomarkers are increasingly playing an important role in improving our understanding of disease and health. Defined as quantifiable and objective behavioral and physiological data collected and measured by digital devices such as implantables, wearables, ingestibles, or portables, digital biomarkers enable pharmaceutical companies to conduct studies remotely without the need for a physical site. This innovative approach is revolutionizing the way pharmaceutical firms conduct research and determine treatment effectiveness.
